compound 21b [PMID: 31430136]   Click here for help

GtoPdb Ligand ID: 10486

Compound class: Synthetic organic
Comment: Compound 21b is an experimental, selective and irreversible inhibitor of LOXL2 that has an aminomethylenethiazole (AMTz) scaffold [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 127.49
Molecular weight 362.09
XLogP 1.28
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCc1cc(cc(c1)S(=O)(=O)c1cnc(s1)CN)c1cnn(c1)C
Isomeric SMILES CCc1cc(cc(c1)S(=O)(=O)c1cnc(s1)CN)c1cnn(c1)C
InChI InChI=1S/C16H18N4O2S2/c1-3-11-4-12(13-8-19-20(2)10-13)6-14(5-11)24(21,22)16-9-18-15(7-17)23-16/h4-6,8-10H,3,7,17H2,1-2H3
InChI Key VIYHDQCOPYIJMF-UHFFFAOYSA-N
Bioactivity Comments
Compound 21b exhibits potent anti-tumour activity in a mouse model of LOX-driven spontaneous breast cancer development [1]. The IC50 for inhibition of LOXL3 is 1250 nM. Compound 21b does not significantly inhibit other amine oxidase enzymes or the hERG potassium ion channel.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
lysyl oxidase like 2 Primary target of this compound Hs Inhibitor Inhibition 6.8 pIC50 - 1
pIC50 6.8 (IC50 1.51x10-7 M) [1]
lysyl oxidase Hs Inhibitor Inhibition 5.5 pIC50 - 1
pIC50 5.5 (IC50 3.3x10-6 M) [1]